Although we provided potential evidence of successful monitoring of serum KL-6 levels in a representative case (Fig. 5e), it was impossible to objectively demonstrate the utility of serum KL-6 monitoring with the small sample size, as the progress of ILD changed. This evidence concerns the gene MUC1 and interstitial lung disease.